KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xylem (XYL) Accumulated Expenses (2016 - 2025)

Xylem has reported Accumulated Expenses over the past 16 years, most recently at $1.2 billion for Q4 2025.

  • Quarterly results put Accumulated Expenses at $1.2 billion for Q4 2025, down 2.68% from a year ago — trailing twelve months through Dec 2025 was $1.2 billion (down 2.68% YoY), and the annual figure for FY2025 was $1.2 billion, down 2.68%.
  • Accumulated Expenses for Q4 2025 was $1.2 billion at Xylem, up from $1.2 billion in the prior quarter.
  • Over the last five years, Accumulated Expenses for XYL hit a ceiling of $1.3 billion in Q4 2024 and a floor of $713.0 million in Q1 2022.
  • Median Accumulated Expenses over the past 5 years was $1.1 billion (2023), compared with a mean of $985.6 million.
  • Biggest five-year swings in Accumulated Expenses: surged 40.83% in 2023 and later fell 4.74% in 2024.
  • Xylem's Accumulated Expenses stood at $752.0 million in 2021, then rose by 15.29% to $867.0 million in 2022, then surged by 40.83% to $1.2 billion in 2023, then increased by 4.1% to $1.3 billion in 2024, then decreased by 2.68% to $1.2 billion in 2025.
  • The last three reported values for Accumulated Expenses were $1.2 billion (Q4 2025), $1.2 billion (Q3 2025), and $1.2 billion (Q2 2025) per Business Quant data.